Luis Eduardo Jáuregui Ilabaca

Urologist @UroINNSZ - Interested in urologic oncology and endourology Fellowship in Endourology and Robotic Surgery @UANL Monterrey

[Luis Eduardo Jáuregui Ilabaca @Edu_Jauregui]

This weekend it's so special 'cause i've finally achieved one of my greatest dreams

Certified Urologist by the @CONAMEU1 and my second home INCMNSZ

Thanks to each and everyone that stood by my side along this amazing journey. My family, friends and professors! This is for you

[Lee Zhao @lee_c_zhao]

@daviesbj It’s not just urologic oncology. Interest in fellowship has shifted across urology.

@societyGURS went from 29 fellows in 2006 to ~300 across 45 states by 2026. Every subspecialty has had some version of this expansion.

Supply, demand, and a few things we do not say out loud. 🧵

https://t.co/s7iKbbNSVq

[Luis Eduardo Jáuregui Ilabaca @Edu_Jauregui]

@SoyCristianRey Venga con todo, maestro Cristian Rey!!!!! @SoyCristianRey

[Fernando GomezSancha @fgomsan]

New in World J Urol (Cindolo et al.): a multicentre series of 10 high-grade Clavien-Dindo complications after Rezum. Septic shock, intraprostatic abscess, bowel injury, 3 deaths — all in patients with negative preop urine culture and standard antibiotic prophylaxis. https://t.co/UWKkkRS4GP

[Luis G. Medina @LuisMedinaMD]

New review on genitourinary sarcomas - A good resource for anyone managing these patients.

Read more: https://t.co/mxaOCns4Dv

Thanks to the team for all their help and contributions to this work - @SpiessPhilippe @LiangChengMD @zcons @MehrazinMD @GTumors

[Laura Bukavina @LauraBukavinaMD]

En bloc cystectomy is proving to be a powerful approach in challenging cx> post-EV/P, bulky fibrotic disease and EV/P progressors ⬆️ R0 %, ⬇️ EBL and improved node # We keep expanding our robotic en bloc cystectomy experience with LN ctDNA measurement .. innovation in tx requires 🤖 innovation in approach . credit to @EirikKjo @CleClinicUro

[Lee Zhao @lee_c_zhao]

when I want to relax, I view surgical technique videos. I can watch these moves by @WithAScalpel for hours. good practice for no touch technique of ureter recon

[Jeff Tosoian, MD, MPH @UroOncJT]

We can say it again - prostate MRI is highly informative when positive, but it is not very informative and often misleading when negative. MRI is simply NOT a reliable rule out test in most settings. Apply clinically with caution. Great talk by Wayne Brisbane. #AUA26

[Alexander Kutikov MD @uretericbud]

Very impressive John K. Lattimer Lecture: Transurethral Robotic en-bloc
TURBT- Challenging the Status
Quo by @jteoh_hk

#bladdercancer surgeons must take note. #aua26

[Abhishek singh @abhisingh82]

Post robotic radical cystectomy , creating stoma was extremely tedious in this patient.
Patient was extremely obese BMI -42.
Did a turnbull stoma and put a red rubber catheter through the mesentery to prevent retraction. As you would do for loop colostomy.
Open to suggestions!!

[Dmitry Enikeev @Dmitry_Enikeev]

Breaking this paradigm.
Large bladder tumors can be safely removed with laser en bloc, followed by morcellation.
High quality pathology. Better outcomes.
Pathologists are happy and so are we.
@DrShariat @shaygo1 @trwherrmann @jteoh_hk @scoffonecesare

[Dra. María Natalia Gandur Quiroga @nataliagandur]

💫🌟 Redefining GU cancer precursors
@EUplatinum @OncoAlert

🌍 ISUP Consensus (Florence) sets a NEW framework for GU premalignant lesions:

🔵 Prostate: IDC → must report (aggressive biology)
🟡 Bladder: CIS remains key precursor
🟠 Kidney: Papillary adenoma = only established precursor
🟢 Testis: GCNIS → definitive precursor
🔴 Penis: PeIN unified classification
📌 Standardization = better diagnosis & clinical decision-making
🔗 https://t.co/RVOunvcaTd
🔗 https://t.co/6m3XottloX
@ecancer @urotoday @MedicalwatchHQ
@ASCOPres @DrYukselUrun @montypal
@PGrivasMDPhD @tompowles1 @shilpaonc
@neerajaiims @UroDocAsh @TiansterZhang
@gbanna74 @katy_beckermann
@DrKarineTawagi
#GUOncology #UroPath #PrecisionMedicine #ProstateCancer #BladderCancer #OncoTwitter

[Álex Maceín @AlexMacein]

“Solo ha subido un poco la creatinina”

💦La Cr no solo estima función renal.También orienta a Insuficiencia Renal Aguda o si se trata de más Enfermedad Renal Crónica…

📉 IRA → pequeños ↑ pueden implicar gran ↓ del FG
📉 ERC → grandes ↑ suelen asociar menor cambio relativo

[NEJM @NEJM]

In cisplatin-ineligible patients with muscle-invasive bladder cancer, enfortumab vedotin–pembrolizumab plus surgery led to better event-free survival (74.7%, vs. 39.4%) and overall survival (79.7%, vs. 63.1%) than surgery alone at 2 years. Full phase 3 KEYNOTE-905 trial results and Research Summary: https://t.co/bzVbmJXHMD

[Mario Sofer @mario_sofer]

How to report prostate volume in HoLEP literature? Preoperative US, TRUS, MRI? Resected tissue weighted in the OR? Pathological report? Is the time for standardization!! ⁦@UrologyTLVMC⁩ ⁦@scoffonecesare⁩ ⁦@fgomsan⁩ ⁦@FCAFigueiredo⁩

[Ryan L. Steinberg MD @ryansteinbergmd]

Must read for all uros since we ALL order CTs w contrast for various reasons. We are part of the fight to change this misconception to ensure our patients get the imaging (and thus care) they need!

@ChadTracyMD @Allyhertz @TheBigLoeb @AmandaMyersMD @baerickson29 @AnnahVollstedt

[Fernando GomezSancha @fgomsan]

Piedras en vejiga + próstata grande: ¿cirugía combinada o por pasos? Nuevo estudio multicéntrico analiza decisiones clínicas y resultados. 
https://t.co/YF2meTeneT

[Michael Hofman @DrMHofman]

Proud moment and HUGE news from #EAU26: #PRIMARY2 shows PSMA PET/CT can safely halve prostate biopsies in men with equivocal MRI, avoiding biopsy in 49% without missing cancer. https://t.co/OOGooac59C

[@DocMeetings - Urology @docmeetings]

PRostate cancer guidelines 2026 update. Digital rectal exam NOW no more recommended for Asymptomatic men

SO NO MORE FOR Screening

Important for standing and for early diagnosis for SYMPTOMS only @Uroweb

[Dr. Carlos Ríos Melgarejo @urologorios]

PRIMARY2 trial
En hombres con sospecha de cáncer de próstata y mpMRI negativa o equívoca:•Sensibilidad:
mpMRI sola → ~83%
mpMRI + PSMA PET → ~94%
El PSMA PET detecta tumores clínicamente significativos no visibles en MRI y mejora la selección para biopsia.
#EAU2026 #PSMAPET

[Ahmed M. Harraz @Ahmed_M_Harraz]

The supine lateral extraperitoneal approach for RPLND is an alternative when transperitoneal surgery is non-friendly. Length of stay < 48 hours.

May Allah keep Kuwait, Egypt and all arabic countries safe and secure 🙏
#RPLND